210 related articles for article (PubMed ID: 26655701)
1. Digit-Sparing Mohs Surgery for Melanoma.
Terushkin V; Brodland DG; Sharon DJ; Zitelli JA
Dermatol Surg; 2016 Jan; 42(1):83-93. PubMed ID: 26655701
[TBL] [Abstract][Full Text] [Related]
2. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
3. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
4. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
5. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
8. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Degesys CA; Powell HB; Hsia LB; Merritt BG
Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
12. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
Seo J; Oh Y; Kim SK; Roh MR; Chung KY
Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
[TBL] [Abstract][Full Text] [Related]
13. Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers.
Husain Z; Allawh RM; Hendi A
Cutis; 2018 May; 101(5):346-352. PubMed ID: 29894522
[TBL] [Abstract][Full Text] [Related]
14. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ
J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704
[No Abstract] [Full Text] [Related]
15. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
17. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
18. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
19. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma.
Temple CL; Arlette JP
J Surg Oncol; 2006 Sep; 94(4):287-92. PubMed ID: 16917877
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
